Tofacitinib: A New Oral Therapy for Psoriasis
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-017-0596-y
Abstract: Psoriasis is a common, chronic, immune-mediated disease associated with several comorbidities. Biologic therapy revolutionized the treatment of moderate-to-severe psoriasis, improving physical and emotional burden of the disease. Still, there are unmet needs in the treatment… read more here.
Keywords: tofacitinib new; therapy; treatment; oral therapy ... See more keywords